HopeStage
Back to all studies
CompletedNCT01528839

L-Thyroxine or Placebo Added for Depression Related to Bipolarity

About this title

Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression

Read the official source — NCT01528839
Medication studyAges 18–65United States + Germany
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Los Angeles and 4 more locationsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2004
Recruitment status
Completed
Enrollment listed in the registry
74
Sponsor
Charite University, Berlin, Germany
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States, Germany
Age range
From 18 Years to 65 Years
Official registry ID
NCT01528839
Official title
Show the full official title

Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Los Angeles, United States · Berlin, Germany · Bochum, Germany

2 more locations
  • Dresden, Germany
  • Göttingen, Germany

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Charite University, Berlin, Germany, a university.

Did this study involve medication?

Yes. The study involved medication, including L-Thyroxine and Placebo.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies